Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-258 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L2-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-258 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
filingDate |
2014-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2016-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2016515611-A |
titleOfInvention |
Brain-activating composition containing ginseng fruit extract |
abstract |
This specification provides the brain activation composition which contains the ginseng fruit extract as an active ingredient. The composition according to the present specification has the effect of increasing the blood flow in the brain and improving chronic fatigue syndrome. In addition, the composition according to the present specification activates the brain, and as a result, improves the accuracy of problem solving in the cognitive ability region by strengthening the connection strength between the frontal lobe and the occipital lobe and reduces the solution time. There is an effect of shortening. For this reason, the composition according to the present specification can be used as a pharmaceutical composition or a food composition for patients suffering from chronic fatigue syndrome. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102065503-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190123045-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019218284-A |
priorityDate |
2013-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |